Angiolutions expands award-winning IP portfolio:
Angiolutions expands award-winning IP portfolio: 11 patents granted Portfolio now comprises 33 patent filings, including 11 granted patents Five patent
News & Updates
Angiolutions expands award-winning IP portfolio: 11 patents granted
Angiolutions' strong intellectual property protection now comprises 33 patent filings, including 11 granted patents.
Angiolutions appoints leading international experts to its Medical Board
Angiolutions treats first patient in clinical investigation of its A³‑Shield® system for early-stage abdominal aortic aneurysms
Second US patent granted in May, first EU patent granted in July; Increasing total patent portfolio to 16 patents and applications; Intellectual property (IP) portfolio protects innovation from multiple angles.
Angiolutions strengthens intellectual property protection for its early aortic aneurysm treatment: second US patent granted
Second US patent granted in May, first EU patent granted in July; Increasing total patent portfolio to 16 patents and applications; Intellectual property (IP) portfolio protects innovation from multiple angles.
Stay in touch
receive update emails a few times a year
Angiolutions in the media
Die tickende Zeitbombe
04.03.2021 | nbank.de
"Angiolutions entwickelt ein neuartiges Gefäßimplantat, das zum ersten Mal eine spezifische minimalinvasive Behandlung kleiner Bauchaortenaneurysmen ermöglicht [...]"
read more
Im Austausch mit der Gesellschaft
16.02.2021 | deutschland.de
"Medizinische Forschung: Isabel Schellinger arbeitet als Ärztin und ist Gründerin eines wissenschaftsbasierten Startups[...]"
read more
Angiolution explained briefly
An easy-to-understand explainer video about the causes and treatment of vascular diseases.
You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationMedia Kit
further content about Angiolutions
Document title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Document title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.